Showing 1 - 7 results of 7 for search 'Loke, J', query time: 0.03s
Refine Results
-
1
-
2
-
3
Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients. by Hughes, D, Hafferty, J, Fulton, L, Friend, P, Devaney, A, Loke, J, Welsh, K, Handa, A, Klenerman, P
Published 2008Journal article -
4
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy by Loke, J, Metzner, M, Boucher, R, Jackson, A, Hopkins, L, Pavlu, J, Tholouli, E, Drummond, M, Peniket, A, Bishop, R, Fox, S, Vyas, P, Craddock, C
Published 2021Journal article -
5
Azacitidine Induces Expansion of Regulatory T Cells and Tumour Specific CD8+T Lymphocytes After Allogeneic Stem Cell Transplantation: A Strategy for Epigenetic Manipulation of a Gr... by Dennis, M, Goodyear, O, Loke, J, Jilani, N, Siddique, S, Ryan, G, Khanum, R, Snowden, J, Griffiths, M, Russell, N, Yin, J, Crawley, C, Cook, G, Vyas, P, Moss, P, Malladi, R, Craddock, C
Published 2011Conference item -
6
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). by Goodyear, O, Dennis, M, Jilani, N, Loke, J, Siddique, S, Ryan, G, Nunnick, J, Khanum, R, Raghavan, M, Cook, M, Snowden, J, Griffiths, M, Russell, N, Yin, J, Crawley, C, Cook, G, Vyas, P, Moss, P, Malladi, R, Craddock, C
Published 2012Journal article -
7
Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia by Craddock, C, Jackson, A, Loke, J, Siddique, S, Hodgkinson, A, Mason, J, Andrew, G, Nagra, S, Malladi, R, Peniket, A, Gilleece, M, Salim, R, Tholouli, E, Potter, V, Crawley, C, Wheatley, K, Protheroe, R, Vyas, P, Hunter, A, Parker, A, Wilson, K, Pavlu, J, Byrne, J, Dillon, R, Khan, N, McCarthy, N, Freeman, SD
Published 2020Journal article